1-3 of 3
Pedro Henrique Arruda De Moraes, MD
Close
Sort by
Journal Articles

Increased Risk of for Cytomegalovirus Reactivation after Allogeneic HSCT in T-Cell Depleted Patients

Vinicius Campos Molla, MD, Roberta Azevedo, Jessica Fernandes Ramos, MD PhD, Danilo Belchior Ponciano, Pedro Henrique Arruda de Moraes, MD, Ana Rita Da Fonseca, MD, Maria Cristina Nunez Seiwald, MD, Mariana Serpa, MD, Aliana Meneses Ferreira, MD, Roberta Shcolnik Szor, MD, Rayana Bomfim Leonel, MD, Erick Menezes Xavier, MD, Vanderson Rocha, MD PhD, Luciana Tucunduva, MD, Yana Novis, MD, Marcio Nucci, MD PhD, Esper Kallas, MD PhD, Celso Arrais, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36–37.
https://doi.org/10.1182/blood-2020-142111
Published: 2020
Journal Articles

Long-Term Follow-up of Ruxolitinib in Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease (GVHD)

Aliana Meneses Ferreira, MD, Vinicius Campos Molla, MD, Maria Cristina Nunez Seiwald, MD, Roberta Shcolnik Szor, MD, Pedro Henrique Arruda De Moraes, MD, Ana Rita Da Fonseca, MD, Mariana Serpa, MD, Erick Menezes Xavier, MD, Luciana Tucunduva, MD, Yana Novis, MD, Celso Arrais-Rodrigues, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-141452
Published: 2020
Journal Articles

"Low Dose Ganciclovir for Cytomegalovirus Reactivation after Allogeneic HSCT Is a Feasible Option with Same Efficacy and Less Toxicity Than Regular Dose"

Roberta Azevedo, Vinicius Campos Molla, MD, Jessica Fernandes Ramos, MD PhD, Danilo Belchior Ponciano, Pedro Henrique Arruda De Moraes, MD, Ana Rita Da Fonseca, MD, Maria Cristina Nunez Seiwald, MD, Mariana Serpa, MD, Aliana Meneses Ferreira, MD, Roberta Shcolnik Szor, MD, Rayana Bomfim Leonel, MD, Erick Menezes Xavier, MD, Luciana Tucunduva, MD, Vanderson Rocha, MD PhD, Yana Novis, MD, Esper Kallas, MD PhD, Marcio Nucci, MD PhD, Celso Arrais-Rodrigues, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-142112
Published: 2020